PTC Therapeutics board approves $500M share repurchase program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 67.60 +6.72 (11.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.88 | 52 Week High | $35.40 | |||
| Open | $64.14 | 52 Week Low | $4.03 | |||
| Day High | $68.15 | P/E | 7.19 | |||
| Day Low | $63.16 | EPS | $9.40 | |||
| Volume | 1,142,205 | |||||
